Empower plus Q96



What makes EMPowerplus Q96 so unique?

microscopeThe majority of vitamin and mineral supplements found in supermarkets and health food stores cannot be easily digested due to the size of the particles and the improper ratios of certain minerals and vitamins that depend on each other for full absorption. Many supplements also contain inferior chelates and low quality ingredients.

The unique formula and the advanced technology used to produce EMPowerplus™Q96 address these common problems, making EMPowerplus™Q96 the highest quality micronutrient formulation available on the market today.

1. Micronization

Using cutting edge technology, minerals are pulverized to a size the body can use. While most supplements are produced in 4 hours, the EMPowerplus™Q96 micronization process takes up to 4 days.

2. Chelation

Minerals are difficult for the body to digest in pure form. To overcome this, EMPowerplus™Q96 minerals go through a rigorous process that wraps them in organic molecules and binds them to proteins the body can easily recognize and digest.

3. Balance

Vitamins and minerals depend on each other for absorption in the body. For example, you need the right amount of zinc to absorb magnesium fully. Similarly, without vitamin D in balance, calcium cannot be readily absorbed. The micronutrients in EMPowerplus™Q96 have been deliberately proportioned and balanced for maximum absorption and effectiveness.

4. Quantity

The average therapeutic dose of EMPowerplus™Q96 provides a full spectrum of micronutrients in high enough doses to sufficiently address deficiencies and promote proper metabolic functioning.

The good news? Current research suggests many symptoms of bipolar, depression, anxiety, and ADHD can be reduced or eliminated using the full-spectrum micronutrient formulation of EMPowerplus™Q96.

Chemical imbalances in the brain

The most common explanation for mood disorders is a chemical imbalance in the brain, but how and why these imbalances happen is not yet known. Since a complex web of nutrients, such as zinc, vitamin B6, and vitamin B12, are the building blocks that the brain needs to make the right amounts of important chemicals such as neurotransmitters, it makes sense that a lack of these nutrients could cause the chemical imbalances of mood disorders.

A genetic need for more nutrients

As early as the 1960s, Dr. Linus Pauling, winner of two Nobel Prizes, speculated that some people have a genetically-based need for more vitamins and minerals than other people. He wondered if mental illness could be the result of failing to meet these extra requirements. Research is now showing that Dr. Pauling may have been right. Dr. Bruce Ames, at the University of California, Berkley, has shown that genetic mutations often result in an increased need for nutrients. He also found that taking extra amounts of these nutrients could correct the deficiencies. If a person with a genetic need for more nutrients does not get them or cannot absorb them, it makes sense that this person would, over time, become deficient.

Lack of nutrients affect brain growth factors

Brain growth factors are necessary for keeping the neuron branches healthy and connected, so that proper signals can be sent. Many nutrients have been shown to increase brain growth factor levels. A lack of these same nutrients leads to brain cell shrinkage and brain cell death. It’s not a stretch to imagine that this could play a significant role in mood disorders.

Nutrients that depend on each other

Numerous studies have been done on the relationship between single nutrients and mental health, but none have ever turned up a “miracle nutrient.” It is believed that a broad spectrum of deficiencies results in the symptoms of mood disorders, not a deficiency of one single nutrient. And since a deficiency in one nutrient has been shown to interfere with the absorption and/or metabolism of other nutrients, a chain reaction can result in multiple deficiencies. This is the foundation of the EMPowerplus™Q96 formulation. It provides a broad spectrum, highly absorbable range of nutrients that are essential to brain function, and it delivers them in a balance that allows inter-dependent nutrients to work together.

EMPowerplus Q96 is a micronutrient and natural remedy for brain health and lifting the darkness of depression and other mood disorders. For more information click here. EMPower Plus Q96 is a nutritional supplement that consists of 14 vitamins, 16 minerals, 3 amino acids, 3 antioxidants. It works by giving the brain the right balance of vitamins and trace minerals on a regular basis. These vitamins must be in critical ratios and balance.

A Utah multilevel-marketing company has a multivitamin to “fix” your mental illness

Crazy Pills

A Utah multilevel-marketing company has a multivitamin to “fix” your mental illness


At an October charity walk in Salt Lake City’s Liberty Park, a cheerful woman is stopping passersby to tell them something miraculous: “It’s for schizophrenia, it’s for bipolar, depression, autism, ADHD, ADD, SAD, OCD—any type of mental illness, these vitamins help.”

Nearby, kids chase balloons while families line up for hot dogs and cookies. Other tents and tables offer information about mental-health services to attendees of the annual walk, held by the National Alliance on Mental Illness. The event, an effort to fight the stigma of mental illness, is for those whose loved ones are dealing with a mental-health issue or who are living with one themselves—and for those who live only with the memories of those lost to the darkness of depression and suicide.

And at the Q Sciences tent, a woman is holding out a light in the darkness, an all-natural supplement that can treat “any mental illness.”

“It’s a vitamin that you take instead of taking your prescription meds,” the woman says with an enthusiastic smile.

This seeming miracle product is a micronutrient formula called EMPower Plus Q96, designed to provide vitamins that, the woman says, are lacking in the brains of those with mental illness.

She cites her husband as a success story; he went off his bipolar medication, thanks to the supplement.

“My 9-year-old has ADHD and I’ve taken him off his meds, he sleeps better and his behavior is the same as if he was on his prescription,” she says.

Yes, EMPower Plus Q96 supporters—and salespeople—hail it as a revolution that will bring relief to millions and loosen the pharmaceutical industry’s chokehold on the mental-health business.

And critics call it snake-oil quackery of the worst kind.

No randomized, controlled tests have demonstrated the efficacy of the supplement, developed in Canada by Mormon business partners. The product’s founders instead cite a number of informal research studies and powerful testimonials.

But while some have had life-changing success stories, others have seen their lives changed for the worse.

In 2011,in Vancouver, British Columbia, the parents of 27-year-old Jordan Ramsay decided they wanted to take their son, who had a long and troubled history with schizophrenia, off his medication in favor of using the EMPower Plus vitamin formula.

Ramsay also had a history of devolving into crisis when he was off his medication, and that pattern continued when he switched to taking only the EMPower Plus supplements. In November 2011, Ramsay used a wrench to bludgeon his parents while they lay in bed, killing his 53-year-old father and severely injuring his mother.

Ramsay’s aunt later told media outside of a 2012 court hearing that Ramsay had believed his parents were aliens and he had to make sure they were dead.

While the product has been sold in the millions of bottles in Canada and is now being marketed and sold in the United States by Q Sciences, the federal Food & Drug Administration doesn’t have anything to say about the productbecause it’s a supplement—meaning that it can’t legally be marketed as a drug that can be used to treat mental illness. But that’s exactly the way Q Sciences distributors touted the product at the NAMI event.

Q Sciences CEO Daren Hogge says he was upset to hear that a distributor selling the product was making such a claim. In an e-mail, Hogge said the woman selling products at the Salt Lake City NAMI Walks would be suspended if the allegations were true. “Compliance is a very serious issue to Q Sciences,” Hogge says.

Rebecca Glathar, the executive director of NAMI Utah, says she’s heard from others about the claims that the Q Sciences distributor was making at the Oct. 19 walk. She says the group paid to join the event the day before it occurred and that NAMI is looking into the matter and will likely re-evaluate the vetting process for vendors who apply for future events.

Though the woman selling the supplement at the NAMI Walks was in violation of federal law and Q Sciences’ own corporate policy, she was also just one of the many distributors in the Q Sciences multilevel marketing (MLM) company. As an MLM, the company markets its products largely through face-to-face meetings, with distributors acting as independent business owners (IBOs) who make monthly payments for Q Sciences products that they then sell to others, who in turn may also become IBOs, with a portion of their profits going up the chain to the IBO who recruited them.

Q Sciences’ Hogge says this “word of mouth” business model saves money on traditional retail costs, allowing those savings to be passed on to IBOs and other customers.

For Utahn Jon Taylor, a longtime critic and MLM watchdog, this business model also allows IBOs to get away with making outrageous claims about what their products can do, without risk of getting caught by the FDA, or the MLM parent corporation being liable if the IBO is somehow caught.

“The company is shielded in some degree from legal action because they can just say, ‘These people are making claims they shouldn’t have’; they can just blame the distributors,” Taylor says.

But do overzealous salesmen make for bad medicine?

Though Q Sciences founding distributor Scott Malone’s statement at a meeting of potential IBOs that “this continues to be and is the most researched product in the history of the world” was hyperbole, EMPower Plus is indeed a well-researched micronutrient formula. The product has been featured in 22 studies, but as ElLois Bailey, a psychiatric mental-health nurse practitioner with University of Utah Health Care, explains, “not all studies are created equal.”

Bailey finds the studies that have looked at Q Sciences’ EMPower Plus Q96 to be lacking in many ways. But, that being said, Bailey is a believer in the role of proper nutrition in helping to improve mental health. She’s studied the topic extensively, and completed her master’s synthesis on the effects of nutrition patterns on late-life depression.

“I hope you can tell I’m passionate about this subject, but I’m also passionate about people not telling others to just go off their medications,” Bailey says.

click to enlarge DarenHoggeKen.jpg

Pain, Pigs and Profit
Depending on whether one is a believer or a skeptic of the EMPower Plus supplement, the origin story of the multivitamin could either be a source of inspiration or the punchline of a joke. For believers, the supplement was the creation of a man desperate to find a remedy to the mental illness that took his wife and threatened his children. For critics, the salient fact is that the design of the supplement was based on a feed recipe given to pigs that were prone to ear-and-tail-biting syndrome. Both stories are true.

Anthony Stephan, a devout member of The Church of Jesus Christ of Latter-day Saints in Alberta, Canada, was away on business when his wife took her life by asphyxiation after affixing a hose to the exhaust pipe of the family minivan. Stephan’s wife had been diagnosed with bipolar-affective disorder, the same ailment that had afflicted her father, who had also taken his life.

Soon after his wife’s death, two of Stephan’s children were also diagnosed with bipolar disorder.

“It was like a nuclear bomb had been dropped right in the living room,” Stephan says on the Q Sciences-produced video The Tony Stephan Story.

Stephan felt that traditional medication didn’t save his wife and wouldn’t help his children. He turned to friend and fellow LDS wardmember Stephen Hardy, whose background was in agriculture as a feed formulator. Hardy suggested a nutritional supplement could be formulated to help Stephan’s children, given that similar symptoms seemed to be exhibited by pigs.

The duo formulated their micronutrient and tested it out on Stephan’s children, who, according to the video, felt an effect and were soon able to discontinue taking their medications.

From there, the duo formed the company Synergy Group of Canada, more commonly known as Truehope, an affiliated nonprofit. Their supplement was a patented, 36-ingredient combination of 34 common vitamins and minerals, including magnesium, zinc, vitamins A, D, E and B, and two antioxidants.

While the product was buoyed by Stephan’s own testimony of the good it had done in his family, it was also supported by a 2001 clinical study that found promise in the supplement’s treatment of mood disorders. Charles Popper of Harvard University’s McLean Hospital tried the supplement on 10 adults, nine adolescents and three pre-adolescents, all of whom had bipolar disorder, and found significant improvement in his patients’ symptoms.

The Harvard approval helped spur greater interest and sales in the EMPower Plus formula, but Canadian health officials were nevertheless concerned that the product was being touted as a drug. In 2003, Royal Canadian Mounted Police raided Truehope headquarters and seized the company’s computer files.

That year, the Canadian health officials of Health Canadaalso issued the first Health Hazard warning against people going off prescription medicine in favor of the product.

In 2006, Health Canada pressed charges against Truehope, arguing that the product was packaged as a drug without approval. Health Canada dropped all but one charge before trial, and eventually lost the case.

But though Truehope has seized on the court case and a handful of supportive research studies as a victory, even researchers who have expressed support of the micronutrient have sounded a cautionary note.

During the trial, Harvard’s Popper told a Canadian court that he would not recommend the supplement as an established treatment without more rigorous study. It’s a statement that echoed a point he made in that promising 2001 study on his patients: “The possibility of a nutritional alternative to drug treatment may raise hope and carry the risk of igniting public interest beyond reasonable bounds.”

Join Q Sciences


Quintessential Bio sciences (Q Sciences) began with the founding principle that if we did the right things for the right reasons, we could create a GREAT Company – a company that could truly make a difference in improving Quality of Life for people throughout the world.

This principle guides all of the decisions we make at Q Sciences.

Doing the right things for the right reasons meant bringing together an executive team and medical advisory staff made up of people who not only have impressive educations, training and professional experience, but who care deeply about helping others.

It means choosing products backed by overwhelming scientific research that have the ability to dramatically change lives for the better.

Doing the right things for the right reasons has meant working with the best consultants to design a compensation plan that provides an income opportunity that is unmatched in the industry.

And it means conducting business with honor and integrity, accountable for our commitments, and being in all things and in all ways completely trustworthy to our IBOs, our customers, and those we associate with.

Marc Wilson, Founder

Click Here to join now!

Empower plus Q96 Research/Studies


, ,



390274_175705862569645_382222252_nSince 1996, scientific researchers and doctors in clinical practice have been studying the effects of Q96™ on mental disorders such as bipolar disorder. Results have been very encouraging and significant.

Dr. Bonnie Kaplan, a respected behavioral research scientist and one of the principal researchers on several of the published studies says, “If substantiated in controlled trials, the normalization of the mentally ill via nutrient supplementation would be the most significant breakthrough in the field of mental illness since the beginning of time.”

Download a free white paper detailing 25 medical journal publishing’s speaking on the effectiveness of Q96™ HERE.


Three of the Independent Research Contributors


charles (1)Dr. Charles Popper is a child and adolescent psychiatrist and psychopharmacologist who has been affiliated with McLean Hospital and Harvard Medical School since the late 1970’s. He established and directed the Child and Adolescent Psychopharmacology program at McLean Hospital for 14 years, and taught the first weekly year-long seminar for psychiatic residents in the country on child and adolescent psychopharmacology.

He organized the large and popular Course in Child and Adolescent Psychopharmacology at the annual meetings of the American Psychiatric Association for 10 years, and led the Special Interest Study Group on Psychopharmacology at the annual meetings of the American Academy of Child and Adolescent Psychiatry for 12 years.

Dr. Popper was the Founding Editor of the Journal of Child and Adolescent Psychopharmacology, the first journal dedicated to child psychopharmacology and biological child psychiatry, and served as Editor in Chief for 7 years. In recent years, he has been pursuing the potential use of multi-vitamin/multi-mineral supplementation as a primary treatment of bipolar disorder and other psychiatric disorders in children and adults.


Bonnie KaplanDr. Bonnie Kaplan has been studying developmental disorders in children for many years, especially attention deficit hyperactivity disorder (ADHD), reading disabilities (dyslexia), and motor problems (Developmental Coordination Disorder). She is part of a team from University of Calgary and University of British Columbia, which is searching for the genes that predispose children to develop dyslexia, and is involved in some family studies of reading and attention problems also. With her students, she has been investigating the characteristics of adults with the challenging disorder of ADHD.

Most recently, she has become interested in the mood symptoms that often accompany behavioral disorders, and she has been studying the role of micronutrient supplementation (vitamins and minerals) for the treatment of mood, aggression, and explosive rage. Three publications containing her preliminary work on the supplement have been published, as well as two replications from psychiatrists in the United States. Formal clinical trials are being reviewed in two countries.


jrucklidgeJulia Rucklidge, PhD is a Professor of Clinical Psychology in the Department of Psychology at the University of Canterbury, Christchurch, New Zealand. Originally from Toronto, she did her training in neurobiology (McGill) and Clinical Psychology (University of Calgary).

Her interests in nutrition and mental illness grew out of her own research showing poor outcomes for children with significant psychiatric illness despite receiving conventional treatments for their conditions. For the last 6 years, she has been investigating the role of micronutrients in the expression of mental illness, specifically ADHD, Bipolar Disorder, anxiety and more recently, stress and PTSD associated with the Canterbury earthquakes.


Abstracts of Published Empirical Reports


1. Rodway, M., Vance, A., Watters, A., Lee, H., Elske, B., & Kaplan, B.J. (2012). Efficacy and cost of micronutrient treatment of childhood psychosis. BMJ Case Reports.

Psychosis is difficult to treat effectively with conventional pharmaceuticals, many of which have adverse long-term health consequences. In contrast, there are promising reports from several research groups of micronutrient treatment (vitamins, minerals, amino acids and essential fatty acids) of mood, anxiety and psychosis symptoms using a complex formula that appears to be safe and tolerable. We review previous studies using this formula to treat mental symptoms, and present an 11‐year-old boy with a 3-year history of mental illness whose parents chose to transition him from medication to micronutrients. Symptom severity was monitored in three clusters: anxiety, obsessive-compulsive disorder and psychosis. Complete remission of psychosis occurred, and severity of anxiety and obsession symptoms decreased significantly (p<0.001); the improvements are sustained at 4-year follow-up. A cost comparison revealed that micronutrient treatment was <1% of his inpatient mental healthcare. Additional research on broad‐spectrum micronutrient treatment is warranted.

2. Frazier, E., Fristad, M., Arnold, E. (2012). Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. Department of Psychiatry, The Ohio State University. Journal of Alternative and Complementary Medicine, vol 18 (7), pp. 678-685.

Objective: Current psychotropic medications for childhood bipolar spectrum disorders (BPSD) are associated with significant adverse events. As nutrients play an important role in physical and mental health, they may be useful in treating mood disorders with few side effects. This open label study explored the feasibility of testing therapeutic effects of a multi-nutrient supplement for pediatric BPSD.

Design: The supplement was started at one capsule t.i.d. and escalated to a goal of four capsules t.i.d., which eight children attained. Four (4) of these increased to the maximum dose, five capsules t.i.d. Mood symptoms were assessed seven times over 8 weeks.

Subjects: Ten (10) children, age 6–12 with BPSD, were enrolled in 6.5 months. Seven (7) participants completed the full trial. Three (3) dropped out due to palatability and/or adherence issues.

Results: Mean medication adherence was 91%. With one-tailed nonparametric Fisher’s randomization tests, intent-to-treat analyses demonstrated a 37% decrease in depression scores (p < 0.06) and a 45% decrease in mania scores (p < 0.01) from the start of treatment through final visit, suggesting improvement and possible treatment response. Study completers demonstrated significant decreasing trends in both depression and mania scores from baseline to final visit (p < 0.05). Side-effects were minor and transient, mostly temporary gastric discomfort. Conclusions: Future randomized, placebo controlled trials of the supplement are warranted and feasible.

3. Rucklidge, J., Andridge, R., Gorman, B., Blampied, N., Gordon, H., & Boggis, A. (2012). Effects of micronutrients on stress and trauma after an earthquake: RCT evidence comparing formulas and doses. Human Psychopharmacology: Clinical and Experimental.

Objective: To compare two micronutrient (vitamins and minerals) formulas (Berocca™ and CNE™) and assess their impact on emotions and stress related to the 6.3 earthquake on February 22nd 2011 in Christchurch, New Zealand.

Methods: 91 adults experiencing heightened anxiety or stress 2–3 months following the earthquake were randomized to Berocca™, CNE™ low dose (CNE4), or CNE™ high dose (CNE8), for 28 days and monitored weekly via on-‐line questionnaires and followed 1 month post-‐trial. A nonrandomized control group (n = 25) completed questionnaires at baseline and 4 weeks.

Results: All treatment groups experienced significant declines in psychological symptoms (p<.001). CNE™ groups experienced greater reduction in intrusive thoughts as compared with Berocca™ (p = .05), with no group differences on other measures of psychological symptoms. However, CNE8 group reported greater improvement in mood, anxiety, and energy (p<.05) with twice as many reporting being “much” to “very much” improved and five times more likely to continue taking CNE™post-‐trial than Berocca™ group. Treated participants had better outcomes on most measures over 4 weeks as compared to controls. Conclusions: This study supports micronutrients as an inexpensive and practical treatment for acute stress following a natural disaster with a slight advantage to higher doses

4. Rucklidge, J., & Blampied, N. (2011). Post-Earthquake Psychological Functioning in Adults with Attention-Deficit/Hyperactivity Disorder: Positive Effects of Micronutrients on Resilience. New Zealand Journal of Psychology, 40(4).

The September, 2010, 7.1 magnitude earthquake in Christchurch, New Zealand, provided an opportunity to study the after effects of a major earthquake where death and injury were absent. It created a natural experiment into the protective effects on well being of taking the micronutrient supplement, in a group of 33 adults diagnosed with ADHD who had been assessed prior to the earthquake. Fortuitously, 16 were currently taking the supplement as part of on going research at the time of the quake, while 17 were not (they had completed their trial or were waiting to begin consumption). The Depression Anxiety and Stress Scale (DASSy 42) which had been administered at varying times before the earthquake on recruitment into the micronutrient study was administered by telephone 7y 10 and again 14y 18 days post earthquake to volunteer, earthquake exposed participants. A modified Brinley plot analysis of the individual DASSy 42 scores showed that the 16 participants on the nutritional supplement were more resilient to the effects of the earthquake than the 17 individuals not taking the supplement. This effect was particularly marked for depression scores.

5. Rucklidge, J., Johnston, J., Harrison, R., & Boggis, A. (2011). Micronutrients reduce stress and anxiety in adults with attention-deficit/hyperactivity disorder following a 7.1 earthquake. Psychiatry Res. 189(2).

The role of good nutrition for resilience in the face of stress is a topic of interest, but difficult to study. A 7.1 earthquake took place in the midst of research on a micronutrient treatment for Attention-Deficit/Hyperactivity Disorder (ADHD), providing a unique opportunity to examine whether individuals with ADHD taking micronutrients demonstrated more emotional resilience post-earthquake than individuals with ADHD not taking micronutrients. Thirty-three adults with ADHD were assessed twice following the earthquake using a measure of depression, anxiety and stress also completed at some point pre‐earthquake (baseline). Seventeen were not taking micronutrients at the time of the earthquake (control group), 16 were (micronutrient group). While there were no between-group differences one week post-quake (Time 1), at two weeks post-quake (Time 2), the micronutrient group reported significantly less anxiety and stress than the controls (effect size 0.69). These between group differences could not be explained by other variables, such as pre- earthquake measures of emotions, demographics, psychiatric status, and personal loss or damage following the earthquake. The results suggest that micronutrients may increase resilience to ongoing stress and anxiety associated with a highly stressful event in individuals with ADHD and are consistent with controlled studies showing benefit of micronutrients for mental health.

6. Rucklidge, J., Johnstone, J., & Harrison, R. (2011). Can micronutrients improve neurocognitive functioning in adults with ADHD and severe mood dysregulation? A pilot study. Journal of Alternative and Complementary Medicine. 17(2).

Objective: Little research has investigated how micronutrients (minerals and vitamins) affect cognitive functioning despite preliminary studies showing they may improve psychiatric functioning.

Intervention: This pilot study investigated the impact of a 36-ingredient micronutrient formula consisting mainly of vitamins and minerals on neurocognitive functioning in 14 adults with Attention-‐Deficit/Hyperactivity Disorder (ADHD) and severe mood dysregulation (SMD). Design: The formula was consumed in an open-label trial over an 8 week period. Outcome Measures: The participants completed tests of memory (Wide Range Assessment of Memory and Learning) and executive functioning (Delis-Kaplan Executive Functioning System and Conners Continuous Performance Test) at baseline and at the end of the trial. A gender and age matched control group of 14 non‐ADHD adults not taking the formula were assessed on the same tests 8 weeks apart in order to investigate the impact of practice on the results.

Results: There were no group differences in ethnicity, socio-economic status and estimated IQ. Significant improvement was observed in the ADHD group, but not the control group, across a range of verbal abilities including verbal learning, verbal cognitive flexibility and fluency, and verbal inhibition. These neurocognitive improvements were large and consistent with improved psychiatric functioning. No changes were noted above a practice effect in visual-spatial memory and there were no improvements noted in reaction time, working memory or rapid naming for either groups.

Conclusions: Although the pilot and open label design of the study limits the generalizability of the results, it supports a growing body of literature recognizing the importance of nutrients for mental health and cognition. The results also provide evidence supporting the need for randomized clinical trials of micronutrients as well as other experimental studies in order to better assess whether improved neurocognitive functioning may contribute to improved psychiatric symptoms.

7. Simpson, J.S.A., Crawford, S.G., Goldstein, E.T., Field, C., Burgess, E., & Kaplan, B.J. (2011). Safety and tolerability of a complex micronutrient formula used in mental health: A compilation of eight datasets. BMC Psychiatry, 11(62).

Background: Theoretically, consumption of complex, multi-nutrient formulations of vitamins and minerals should be safe, as most preparations contain primarily the nutrients that have been in the human diet for millennia, and at safe levels as defined by the Dietary Reference Intakes. However, the safety profile of commercial formulae may differ from foods because of the amounts and combinations of nutrients they contain. As these complex formulae are being studied and used clinically with increasing frequency, there is a need for direct evaluation of safety and tolerability.

Objectives: The aim of this project was to compile all known safety and tolerability data collected on one complex nutrient formula.

Data sources and results: Data were assembled from all the known published and unpublished studies for the complex formula with the largest amount of published research in mental health. Biological safety data from 144 children and adults were available from six sources: there were no occurrences of clinically meaningful negative outcomes/effects or abnormal blood tests that could be attributed to toxicity. Adverse event (AE) information from 157 children and adults was available from six studies employing the current version of this formula, and only minor, transitory reports of headache and nausea emerged. Only one of the studies permitted a direct comparison between micronutrient treatment and medication: none of the 88 pediatric and adult participants had any clinically meaningful abnormal laboratory values, but tolerability data in the group treated with micronutrients revealed significantly fewer AEs and less weight gain.

Conclusions: This compilation of safety and tolerability data is reassuring with respect to the broad-spectrum approach that employs complex nutrient formulae as a primary treatment.

8. Rucklidge, J., & Harrison, R. (2010). Successful Treatment of Bipolar Disorder II and ADHD with a Micronutrient Formula: A Case Study. CNS Spectrums. 15(5), 231-237.

Bipolar Disorder with co‐occurring Attention-Deficit/Hyperactivity Disorder (ADHD) is a challenge to treat. Ten previous reports have shown potential benefit of a micronutrient treatment (consisting mainly of vitamins and minerals) for various psychiatric symptoms, including mood and ADHD. This case study aimed to investigate the longer impact of the micronutrients on both psychiatric and neurocognitive functioning in an ABAB design with one year follow up. A 21- year old female with Bipolar II Disorder, ADHD, Social Anxiety and Panic Disorder entered an open-label trial using a nutritional treatment following a documented 8-year history of ongoing psychiatric symptoms not well managed by medications. After 8 weeks on the formula she showed significant improvements in mood, anxiety and hyperactivity/impulsivity. Blood test results remained normal after 8 weeks on the formula. She did not report any adverse side effects associated with the treatment. She then chose to come off the formula; after 8 weeks her depression scores returned to baseline, and anxiety and ADHD symptoms worsened. The formula was reintroduced, showing gradual improvement in all psychiatric symptoms. KT’s case represents a naturalistic ABAB design showing on-off control of symptoms. After one year, she is now in remission of all mental illness. Neurocognitive changes mirrored behavioral changes, showing improved processing speed, variability in response and verbal memory. A placebo response and expectancy effects cannot be ruled out although previous poor response to treatment and the duration of the current positive response decrease the likelihood these other factors better explain change. These consistently positive outcomes alongside an absence of side effects indicate that further research, particularly larger and more controlled trials, is warranted using this multi-nutrient approach.

9. Rucklidge, J., Gately, D., & Kaplan, B.J. (2010). Database analysis of children and adolescents with Bipolar Disorder consuming a micronutrient formula. BMC Psychiatry, 10(74).

Background: Eleven previous reports have shown potential benefit of micronutrient treatment for psychiatric symptoms. The current study asked whether children (7-18 years) with pediatric bipolar disorder (PBD) benefited from the same micronutrient formula; the impact of Attention- Deficit/Hyperactivity Disorder (ADHD) on their response was also evaluated.

Methods: Data were available from 120 children whose parents reported a diagnosis of PBD; 79% were taking psychiatric medications that are used to treat mood disorders; 24% were also reported as ADHD. Using Last Observation Carried Forward (LOCF), data were analyzed from 3 to 6 months of micronutrient use.

Results: At LOCF, mean symptom severity of bipolar symptoms was 46% lower than baseline (effect size (ES) >0.78) (p < 0.001). In terms of responder status, 46% experienced >50% improvement at LOCF, with 38% still taking psychiatric medication (52% drop from baseline) but at much lower levels (74% reduction in number of medications being used from baseline). The results were similar for those with both ADHD and PBD: a 43% decline in PBD symptoms (ES = 0.72) and 40% in ADHD symptoms (ES = 0.62). An alternative sample of children with just ADHD symptoms (n = 41) showed a 47% reduction in symptoms from baseline to LOCF (ES = 1.04). The duration of reductions in symptom severity suggests that benefits were not attributable to placebo/expectancy effects. Similar findings were found for younger and older children and for both sexes.

Conclusions: The data are limited by the open label design, the lack of a control group, and the inherent self-selection bias. While these data cannot establish efficacy, the results are consistent with a growing body of research suggesting that micronutrients appear to have therapeutic benefit for children with PBD with or without ADHD in the absence of significant side effects and may allow for a reduction in psychiatric medications while improving symptoms. The consistent reporting of positive changes across multiple sites and countries are substantial enough to warrant a call for randomized clinical trials using micronutrients.

10. Mehl‐Madrona, L., Leung, B., Kennedy, C., Paul, S., & Kaplan, B.J. (2010). Micronutrients versus standard medication management in autism: a naturalistic case– control study. Journal of Child and Adolescent Psychopharmacology, 20(2), 95-103.

Autism spectrum disorder (ASD) is often accompanied by self-injurious behavior (SIB), aggression, and tantrums, symptoms that have reportedly improved with micronutrient (vitamins and minerals) treatment. The current study took advantage of naturally‐occurring differences in parental preferences for treatment approaches. The Micronutrient Group asked for treatment without pharmaceuticals (n = 44, aged 2-28 yrs at entry (M = 8.39, + 5.58)). Their records were matched with those of 44 similar children whose families requested conventional treatment (Medication Group). Both groups improved on both the Childhood Autism Rating Scale and the Childhood Psychiatric Rating Scale (all p’s < 0.0001). Both groups also exhibited significant decreases in total Aberrant Behavior Checklist scores, but the Micronutrient Group’s improvement was significantly greater, p < 0.0001. SIB Intensity was lower in the Micronutrient Group at the end of the study (p = 0.005), and improvement on Clinical Global Impressions was greater for the Micronutrient Group, p = 0.0029. It is difficult to determine whether the observed changes were exerted through improvement in mood disorder or through an independent effect on autistic disorder. There were some advantages to treatment with micronutrients: lower activity level, less social withdrawal, less anger, better spontaneity with the examiner, less irritability, lower intensity SIB, markedly fewer adverse events, and less weight gain. Advantages of medication management were insurance coverage, fewer pills, and less frequent dosing.

11. Rucklidge, J.J., Taylor, M. R., Whitehead, K. A. (2010). Impact of a micronutrient formula on ADHD and mood Dysregulation in adults with ADHD: Evidence from an 8- week open label trial with natural follow-up. Journal of Attention Disorders.

Objective: To investigate the impact of a 36‐ingredient micronutrient formula consisting mainly of minerals and vitamins in the treatment of adults with both Attention-‐deficit/hyperactivity Disorder (ADHD) and severe mood Dysregulation (SMD).

Method: 14 medication-free adults (9 men, 5 women; 18-55 years) with ADHD and SMD completed an 8-week open-label trial.

Results: A minority reported transitory mild side effects. Significant improvements were noted across informants (self, observer, clinician) on measures of inattention and hyperactivity/impulsivity, mood, quality of life, anxiety, and stress all with medium to very large effect sizes (all p’s < .01); however, the mean of inattention remained in a clinical range whereas the means on measures of mood and hyperactivity/impulsivity were normalized. Follow-up data showed maintenance of changes or further improvement for those who stayed on the micronutrients.

Conclusions: Although this study, as an open trial, does not in itself prove efficacy, it provides preliminary evidence supporting the need for a randomized clinical trial of micronutrients as treatment for the more complex presentations of ADHD.

12. Gately, D., Kaplan, B.J. (2009). Database analysis of adults with bipolar disorder consuming a micronutrient formula. Clinical Medicine: Psychiatry, 4, 3‐16.

Background: Bipolar disorder is a lifelong problem with imperfect available treatments. Recent research has shown potential benefit of nutritional treatment for mood symptoms. The goal of the current study was to determine whether adults with bipolar disorder reported treatment benefit from consuming a micronutrient formula.

Methods: Self-report data were available from 682 adults who reported a diagnosis of bipolar disorder; 81% were taking psychiatric medications. Those reporting additional diagnoses were excluded, as well as those who provided data <60 times during 180 days of using the micronutrients, leaving 358 for analysis.

Results: Mean symptom severity was 41% lower than baseline after 3 months (effect size = 0.78), and 45% lower after 6 months (effect size = 0.76) (both paired t‐tests significant, p < 0.001). In terms of responder status, 53% experienced >50% improvement at 6 months. Half the sample were taking medications approved for bipolar disorder (lithium, anticonvulsants, atypical antipsychotics), and half were either medication-free or taking other medications: the magnitude of treatment benefit t did not differ between these two groups. Regression analyses indicated that decreased symptom severity over the 6 months was associated with increasing micronutrient dosage and with reducing medication. Symptom improvements were significant and sustained at 6 months, suggesting that benefits were not attributable to placebo/expectancy effects.

Conclusions: Further research on this micronutrient formula is warranted.

13. Rucklidge, J. J. (2009). Successful treatment of OCD with a micronutrient formula following partial response to CBT: A case study. Journal of Anxiety Disorders, 23, 836–840.

Obsessive Compulsive Disorder (OCD) affects 0.5–2% of young people many of whom are resistant to conventional treatments. This case study describes an 18-year‐old male with OCD who first underwent cognitive behavioral therapy (CBT) for a 1-year period with a modest response (his OCD had shifted from severe to moderate). Within a year, his anxiety had deteriorated back to the severe range and he now had major depression. He then entered an ABAB design trial using a nutritional formula consisting mainly of minerals and vitamins (together, known as micronutrients). After 8 weeks on the formula, his mood was stabilized, his anxiety reduced, and his obsessions were in remission. The treatment was then discontinued for 8 weeks, during which time his obsessions and anxiety worsened and his mood dropped. Reintroduction of the formula again improved the symptoms. This case illustrates the importance of considering the effect micronutrients have on mental illness.

14. Frazier, E., Fristad, M., & Arnold, L. (2009). Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 19(4), 453-460.

Early‐onset bipolar disorder has significant morbidity and mortality. Development of safe, effective treatments to which patients will adhere is critical. Pharmacologic interventions for childhood bipolar spectrum disorders are limited and are associated with significant risk for adverse events (Kowatch et al 2005). Diet and nutrition research suggests vitamins, minerals, and other nutrients are important underpinnings of general physical and mental health; further, they may even be useful in treating mood dysregulation by providing a more favorable risk-‐benefit ratio than contemporary psychotropic agents (Kaplan, Crawford, Field, & Simpson 2007).

This article reviews the literature on multi-nutrient supplementation and mental health, and examines a case study of a 12-year‐old boy with bipolar disorder and comorbid diagnoses treated for 6 years with conventional medication and finally a multi-nutrient supplement.

The multi-nutrient supplement in this case study is a 36-ingredient supplement containing sixteen minerals, fourteen vitamins, three amino acids and three antioxidants. It was used to treat a 12- year old boy initially diagnosed with bipolar disorder not otherwise specified (BPy NOS) at age 6, whose diagnosis evolved by age 10 to bipolar I (BPy I), mixed, with psychotic features. He also met criteria for generalized anxiety disorder by age 8 and obsessively compulsive disorder by age 10. After six years of conventional treatment (ages 6y 12), he received fourteen months of the supplement. Symptom manifestation over seven years is described in conjunction with treatment history. The supplement resulted in superior outcome to conventional treatment.

15. Kaplan, B.J., Fisher, J.E., Crawford, S.G., Field, C.J., & Kolb, B. (2004). Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. Journal of Child and Adolescent Psychopharmacology, 14(1), 115‐122.

Several studies have demonstrated that psychiatric symptoms such as depression, mood swings, and aggression may be ameliorated by supplementation with broad-‐based nutrient formulas containing vitamins, minerals, and sometimes essential fatty acids. These findings have been reported in young criminal offenders as well as in adults with mood disturbance and other psychiatric disorders. The purpose of the current case series was to explore the potential efficacy of a nutrient supplement in children. Children with mood and behavioral problems (N = 11; 7 boys, 4 girls; 8–15 years old) participated; 9 completed this open-label trial. Parents completed the Child Behavior Checklist (CBCL), Youth Outcome Questionnaire (YOQ), and Young Mania Rating Scale (YMRS) at entry and following at least 8 weeks of treatment. Intent-‐to-‐treat analyses revealed decreases on the YOQ (p < 0.001) and the YMRS (p < 0.01) from baseline to final visit. For the 9 completers, improvement was significant on seven of the eight CBCL scales, the YOQ, and the YMRS (p values from 0.05–0.001). Effect sizes for all outcome measures were relatively large. The findings suggest that formal clinical trials of broad nutritional supplementation are warranted in children with these psychiatric symptoms.

16. Halliwell, C., & Kolb, B. (2003). Diet can stimulate functional recovery and cerebral plasticity after prenatal cortical injury in rats. Soc Neuro Abs, 29.

Early cortical injury has been attributed to the consequential effects of various factors, such as alcohol, drug addiction, smoking, and inadequate nutrient intakes during periods of pregnancy and lactation, or delivery of infants by forceps, and premature deliveries. These are only a few examples of circumstances, or “injury”, that may result in disorders ranging from mild learning difficulties to aggressive behavior. Injury to the cortex during the early years of development has been known to result in poor behavioral outcome into adulthood. Presently, the most common form of treatment includes a pharmacological agent, which may be accompanied with behavioral modification therapies supported by families. As an alternative form of therapy towards the treatment of early cortical injury, choline and a vitamin and mineral supplement were used to determine the possibilities of nutrition intervention in an animal model. The injuries were incurred by aspiration lesion at days three and four, and lesions were localized to the midline medial frontal cortex in some rats, while a different group of rats received lesions in the posterior parietal cortex. The pre and postnatal choline treated animals showed favorable results for the medial frontal lesions, and the postnatal vitamin supplement treated animals showed favorable results for treatment in both medial frontal and posterior parietal lesions. All animals were tested in adulthood indicating that nutrition intervention is very beneficial for alleviating some of the functional deficits commonly seen from early cortical injury.

17. Kaplan, B.J., Crawford, S.G., Gardner, B., & Farrelly, G. (2002). Treatment of mood liability and explosive rage with minerals and vitamins: two case studies in children. Journal of Child and Adolescent Psychopharmacology, 12(3), 203-218.

A micronutrient supplement containing a broad range of dietary minerals and vitamins is being examined for the treatment of mood liability in both adults and children (Kaplan et al. 2001; Popper 2001). During pilot work, two medication-free boys with mood liability and explosive rage were studied in an open-‐label treatment followed by reversal and retreatment. One child was an 8-year‐old with atypical obsessive-compulsive disorder, and the other was a 12-year‐old with pervasive developmental delay. Both boys were monitored using the mood and temper items from the Conners Parent Rating Scale, as well as the Child Behavior Checklist. In addition, the boy with atypical obsessive-compulsive disorder was monitored with the child version of the Yale-Brown Obsessive Compulsive Scale. Both boys benefited from the micronutrient supplement when examined in ABAB designs: mood, angry outbursts, and obsession symptoms improved when initially treated, returned when not taking the supplement, and remitted when the micronutrient supplement was reintroduced. Both boys have been followed and are stable on the nutritional supplement for over 2 years. These cases suggest that mood liability and explosive rage can, in some cases, be managed with a mixture of biologically active minerals and vitamins, without using lithium or other traditional psychopharmacologic agents.

18. Simmons, M. (2003). Nutritional Approach to Bipolar Disorder. Journal of Clinical Psychiatry, 64, 338.

Summary: In a letter to the editor of the Journal of Clinical Psychiatry Dr. Miles Simmons, a psychiatrist in private practice in Brunswick, Maine reported on his clinical experience with the Q96® formula. Impressed by a striking response in a patient who approached him, and after discussing the issues with several of his treatment-resistant patients, he conducted an open trial study with 19 patients from his private practice under careful supervision. His results corroborate Dr. Kaplan’s initial findings. All patients met the DSM-IV criteria for bipolar I (n = 14) or bipolar II (n = 5) and were followed for a mean of 13 months. Of the 19 patients, 16 were already taking medications (mean = 2.7 psychiatric medications). Dr. Simmons observed that “12 of the 19 patients showed marked clinical improvement, 3 showed moderate improvement, and 1 showed mild improvement” (84%). Thirteen of the 16 medicated patients were able to completely discontinue psychiatric medications over an average of 5.2 weeks (range, 3 to 10 weeks) and maintained stability on the Q96® formula alone.

19. Popper, C.W. (2001). Do vitamins or minerals (apart from lithium) have moodstabilizing effects? Journal of Clinical Psychiatry, 62, 933‐935.

Summary: Harvard University (McLean Hospital) clinician, psycho-pharmacologist and Psychiatrist Dr. Charles Popper published commentary including the results of his clinical experience with the Q96® formula. In Dr. Popper’s practice, out of 22 patients (10 adult, 9 adolescent, 3 preadolescent) that clinically met criteria for bipolar disorder, 19 showed what he judged to be a positive response. Of the 15 patients who were being treated with medications when they began the nutritional supplement, 11 patients have been stable for 6 to 9 months without psychiatric medications. Dr. Popper’s findings support Dr. Kaplan’s observations that over 80% of patients saw significant improvement.

20. Kaplan, B. J., Simpson, J. S. A., Ferre, R. C., Gorman, C., McMullen, D., & Crawford, S. G. (2001). Effective mood stabilization in bipolar disorder with a chelated mineral supplement. Journal of Clinical Psychiatry, 62, 936‐944.

Background: To determine in open trials the therapeutic benefit of a nutritional supplement for bipolar disorder.

Method: The sample consisted of 11 patients with DSM-IV-diagnosed bipolar disorder aged 19 to 46 years, who were taking a mean of 2.7 psychotropic medications each at a study entry. Three additional patients dropped out prematurely. The intervention is a broad-based nutritional supplement of dietary nutrients, primarily chelated trace minerals and vitamins, administered in high doses. At study entry and periodically thereafter, patients were assessed with the Hamilton Rating Scale for Depression (HAM‐D), the Brief Psychiatric Rating Scale (BPRS), and the Young Mania Rating Scale (YMRS).

Results: For those who completed the minimum 6-month open trial, symptom reduction ranged from 55% to 66% on the outcome measures; need for psychotropic medications decreased by more than 50%. Paired t tests revealed treatment benefit on all measures for patients completing the trial: HAM-D mean score at entry =19.0, mean score at last visit = 5.4, t = 5.59, df = 9, p< .01; BPRS mean score at entry = 35.3, mean score at last visit = 7.4, t = 2.57, df = 9, p < .05; YMRS mean score at entry = 15.1, mean score at last visit = 6.0, t = 4.11, df = 9, p < .01. The effect size for the intervention was large (> .80) for each measure. The number of psychotropic medications decreased significantly to a mean ± SD of 1.0 ± 1.1 (t = 3.54, df = 10, p < .01). In some cases, the supplement replaced psychotropic medications and the patients remained well. The only reported side effect (i.e. nausea) was infrequent, minor, and transitory.

Conclusion: Some cases of bipolar illness may be ameliorated by nutritional supplementation. A randomized, placebo controlled trial in adults with bipolar I disorder is currently underway, as well as open trials in children.

Review of Articles on Micronutrients in Mental Health

1. Hurt E., Lofthouse N., & Arnold L.E. (2011). Complementary and Alternative Biomedical Treatments for ADHD. Psychiatric Annals, 41(1).

2. Kaplan, B.J. & Leung, B. (2011). Micronutrient treatment of mental disorders. IntegrativeMedicine, 10(3).

3. Shaw I., Rucklidge J. J., Hughes R. N. (2010). A possible biological mechanism for the B Vitamins altering behavior in ADHD. Pharmaceutical Medicine, 24 (5), 1-6.

4. McCann, J.C., & Ames, B.N. (2009). Vitamin K, an example of triage theory: Is micronutrient inadequacy linked to diseases of aging? The American Journal of Clinical Nutrition, 90, 889-907.

5. Rucklidge, J.J., Johnstone, J., & Kaplan, B.J. (2009). Nutrient supplementation approaches in the treatment of ADHD. Expert Review of Neurotherapeutics, 9(4), 461-476.

6. Kaplan, B.J., Crawford, S., Field, C., & Simpson, J.S.A. (2007). Vitamins, minerals, and mood. Psychological Bulletin, 33(5), 747-760.

8. Kaplan, B.J. & Shannon, S. (2007). Nutritional aspects of child and adolescent psychopharmacology. Psychiatric Annals, 37(7), 519-528. Reprinted in Pediatrics Annals, 36(9), 600-609.

9. Ames, B.N. (2004). A role for supplements in optimizing health: The metabolic tune-up. Archives of Biochemistry and Biophysics, 423, 227-234.

Empowwer plus Q96 changing Lives



My Q Health Header

“The majority of wellness supplements currently available are shallow, unimaginative and do not contain effective dosing or balance. They lack the potency and synergistic foundational benefits available with Qssentials.” –Dr. Kimberley


Q Sciences is built on a foundation of proven science. Our biologically balanced products are created with innovative research-based formulas, use the highest quality ingredients available, and benefit from cutting-edge technology in nutrient delivery and effectiveness.

Because environmental factors, toxins, and the stresses of daily life can leave us depleted of energy, vitality and essential nutrients, our formulations are engineered to work in harmony to Purify, Optimize, and Protect both mind and body to help you be your best, most vibrant self.


Q96: Research and Resources

Q96 is specifically formulated to provide essential nutritional support to the brain and central nervous system.

Q96 delivers a well-balanced blend of 36 vitamins, minerals, and amino acids to the brain in a safe and effective dose to boost mood stability, mental clarity, and overall brain health in both children and adults. A proprietary 96-hour micronization and nano-chelation process increases the bioavailability of these nutrients for maximum nutrient uptake in the brain.

Q96 has been studied in a variety of human conditions and is backed by scientific research at fifteen universities (including Harvard) in four countries, as well as research published in peer-reviewed journals.

Twenty-five published studies demonstrating effectiveness have led to several ongoing double-blind placebo controlled clinical trials. All research has been conducted independently with no funding from Q Sciences.

Empower plus Q96 Questions and asnwers




What has medical research learned about Q96? Q96 is proven safe (as all ingredients are commonly consumed and have been followed since the 1930’s in public safety registries). Proven more effective than any other standard bipolar therapy in preliminary studies. Side effects are limited to mild digestive upset and occasional headache when taken without food. It takes several weeks to show full effect in symptom reduction. EMP+ is dependent on a reasonably healthy digestive system to be used to full benefit and cannot be taken long-term in conjunction with other psychiatric medications.

What medical research has been done on Q96™?
Q96™ is the most studied micronutrient in the world. It has been independently studied in 3 countries, has 20 medical journal publications with 14 being peer-reviewed. A phenomenal .85 effect size was reported.

Does Q96™ contain any drugs?
No, it contains only vitamins, minerals, amino acids and antioxidants.

How could vitamins and minerals work where drugs have failed?
Many people end up using Q96™ because drugs have not worked for them. Research has shown that people who have mental illnesses seem to need more of certain vitamins and trace minerals. Q96™ works by giving the brain an optimized balance of vitamins and trace minerals on a regular basis. The hypothesis is that the nutrients go to the root cause of imbalances rather than just treating the symptoms.

Is Q96™ safe to use?
The U.S. Institute of Medicine and Health Canada has published detailed information on safe levels of vitamins and minerals. Based on this information, the most serious risk of taking Q96™ is minor, temporary gastrointestinal upset that could occur in a few people.

What’s the difference between Q96™ and a regular multivitamin?
Q96™ contains a broad spectrum of vitamins and trace minerals that go through a rigorous four step process to makes them more easily utilized by the body. The nutrients are micronized and chelated so the body can digest them. They are then balanced in optimum ratios to facilitate absorption and high enough doses to be effective.

Why are the ratios of nutrients so important?
Deficiency of one nutrient can make you unable to absorb other nutrients properly, which leads to multiple, inter-related deficiencies. These deficiencies seem to disrupt the brain chemical function in people with disorders such as bipolar disorder, depression, ADHD, and anxiety.

How do you know it’s not just a placebo effect?
Numerous studies on the placebo effect have shown that a placebo effect only lasts a short time. Then the effect disappears and symptoms return. Q96™ does not “stop working.” Even the first Q96™ users who started in 1996 remain symptom-free and drug-free.

Are there any side effects?
Q96™ produces very few side effects in users and usually just include minor stomach upset as your body gets used to the formulation. People who are transitioning from medications may experience side effects from withdrawal.

How do I know Q96 is for me?
Q96 is a foundational brain supplement that provides your central nervous system with a balanced supply of micronutrients for optimal brain function. Everyone can benefit from daily use of Q96.

Does it work for everyone?
Q96™ has a very high success rate, but nothing promises 100% success for treating mental illness.

How soon will I see results?
No two people have exactly the same experience with starting Q96. Factors such as age, general health, medication use and lifestyle can all affect the speed of recovery. While some may have a more difficult time at the beginning than others, we have seen even very heavily medicated, sick people become well over time.

Can Q96 be taken by children?
As a multi-vitamin and mineral supplement, Q96 is 100% natural and safe. Many children with behavioral issues or mood disorders have been helped by the Q96 formulation.

Can I use Q96 if I am lactose or gluten intolerant?
Yes. Q96 is gluten and dairy free.

Can I take EMPowerplus Advanced™ if I am pregnant or nursing?
Although EMPowerplus Advanced™ is all natural, you should always check with your doctor before starting any new supplement programs.

How does EMPowerplus Advanced™ interact with other supplements or medications?
Due to the potency and powerful formulation of EMPowerplus Advanced™ we don’t recommend using it long term in conjunction with any psychotropic drugs. Always consult your doctor or healthcare specialist for medical advice before starting a new supplement regimen such as EMPowerplus Advanced™. The Support Coaches at MicroNutrient™ Support Services are specially trained to work with those who are on medications or who wish to reduce their medication dosages.

How is taking EMPowerplus Advanced™ for my symptoms better than taking medication?
Most medications attempt to address the symptoms of vitamin and mineral deficiencies and not the core issue of imbalance. Rather than covering up the symptoms with medication, EMPowerplus Advanced™ aims to address the core concerns and eliminate deficiencies that cause many symptoms related to mood disorders.

What is the recommended dosage for EMPowerplus™Q96 for children and adults?
The recommended dosage for adults is two capsules or tablets twice per day. This is the dosage contained in each daily pack of Qssentials.

For children, the recommended dosage varies by age. For children one year old and younger, the recommended dosage is, on average, the equivalent of one capsule per day. For children ages 2-3, the recommended dosage is, on average, the equivalent of two capsules per day. For children ages 3-5, the recommended dosage is, on average, the equivalent of three capsules per day. For children five years and above, the recommended dosage is, on average, the equivalent of four capsules per day.

Can EMPowerplus™Q96 cause stomach upset?
Though EMPowerplus™Q96 has very minimal side effects, some may experience stomach upset due to the vitamin and mineral content, especially when first taking the product. Taking EMPowerplus™Q96 with food, such as a banana or yogurt can help ease the problem.

Can EMPowerplus™Q96 cause headaches?
Though rare, some may experience headaches when first taking the product, due to the mineral and vitamin content. If headaches occur, we recommend that you reduce your daily intake to one tablet or capsule daily, and slowly increase to one twice per day, up to the recommended dosage of two twice per day.

Can I stop taking my other prescribed medications now that I’m taking Qssentials and/or EMPowerplus™Q96?
Q Sciences does not prescribe or claim to cure, prevent or mitigate any disease. Do not change your course of prescribed medication without consulting your health care provider.

Should I take other supplements with Qssentials?
Qssentials provides a great foundation for brain and overall body health. Consult with your health care provider if you have a medical condition that requires additional supplementation.

What is MicroNutrient Support™? How can I contact them?
MicroNutrient Support™ is an independent, third party specializing in micronutrient and mental health research and education. Over the last 15 years, MicroNutrientSupport™ has the most extensive collection of data and research about micronutrient products and supplementation programs available anywhere in the world. They provide this information to individuals and health care providers. If you have questions about EMPowerplus™Q96 that aren’t addressed, you may contact MicroNutrient Support™ at 1-866-397-3116 begin_of_the_skype_highlighting 1-866-397-3116 FREE  end_of_the_skype_highlighting or at http://www.micronutrientsupport.com.

Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. The products mentioned are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Information is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional.

Transitioning From Psychiatric Medications

Do medications interfere with Q96?
Yes, especially psychiatric medications. As your brain function improves, you can become increasingly over-medicated. Psychiatric medications should be gradually tapered off under the supervision of a doctor when using Q96.

What should I expect when transitioning from medications?
As you build up the key nutrient balance in your body, medications can become an issue. Making the transition from psychiatric medications to Q96 must be done with proper supervision. Please DO NOT adjust medications on your own as medication withdrawal symptoms can be quite severe. After the transition period, most of our users find that they enjoy the benefits of mental health without the side effects that they experienced on drugs.

I’m tired of drugs. Can’t I just stop taking them now and switch to Q96?
In addition to your doctor and the Q96 Support team, we highly recommended that you enlist the help of a support person. This could be a counselor, therapist, family member or good friend who is willing to commit to helping you through the transition process, help monitor your symptoms and stay in regular contact with you and Q96 Support.

Study Finds 1 in 5 Americans Lives With a Mental Illness


Study Finds 1 in 5 Americans Lives With a Mental Illness

Almost 44 million adults experienced a mental illness last year. (Photo by Gary Waters/Ikon Images/Corbis)

In the hit series Homeland, Claire Danes plays Carrie Mathison, a high-functioning, quick-on-her-feet CIA agent who also has bipolar disorder. She initially hides her mental illness from her coworkers, but as the series progresses, she is forced to reveal her secret and cope with its implications. Spoiler alert: In this week’s episode, for example, Mathison learned that she was drugged by someone working with Pakistan’s intelligence service who swapped out her bipolar medication for pills that make her hallucinate.

Aside from the espionage and near-death experiences she frequently encounters, Mathison’s situation isn’t much different from that of many Americans diagnosed with mental illness, who lead full and productive lives with their condition. “I think a lot of people think of mental illness as the disheveled homeless man, or the person walking down the street [talking] to themselves, but it’s not. It’s your friend, it’s your neighbor, it’s the person down the street,” says Peter Delany, Ph.D., director of the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality. “It’s not just a few people, it’s a lot of people, and they struggle.”

In fact, a government study released today showed that 18.5 percent of American adults had a diagnosable mental illness in 2013.

Related: The Number One Health Risk for Successful Women

The new findings are based on survey responses from more than 67,800 people ages 12 and older, and reveal a picture of mental health that is vastly different from the stereotypes Delany cites. For one, in about three-fourths of mental illness cases, symptoms do not significantly interfere with a person’s life. Someone with severe depression might miss work because of an episode, Delany explains. And the highest rate of mental illness was among people ages 29 to 45, at nearly 22 percent.

Many people don’t get help for their condition, the study also found. Of the nearly 44 million people with mental illness in the U.S., about 45 percent received treatment in the previous year. Treatment rates were higher, at about 68 percent, among people with severe mental illness.

Nearly 4 percent of American adults, 9.3 million people in total, had serious suicidal thoughts in the past year. And 1.3 million actually attempted suicide, according to the survey.

Related: 8 Foods That Boost Your Mood

“Mental illness is a real health condition, and addressing it [will] help with all kinds of issues,” Delany says, adding that people with mental illness often also experience diabetes, high blood pressure and heart conditions. “It’s critical for everyone to know that there are effective, evidence-based interventions — both social, psychological and pharmaceutical — to help people deal with these problems.”

The uplifting message: Recovery is possible. “Just because you have a mental illness doesn’t mean that you can’t live a full life,” Delany stresses. “With proper treatment and support from your family and community, you can lead a healthy and active life.”

Consider these resources if you or someone you know is coping with a mental health issue:

To find treatment or support resources near you: Visit SAMHSA’s Behavioral Health Treatment Services Locator to find local mental health services. You can search by ZIP code to receive a list of the different options available in your area.

To improve your mental well-being on your own: Check out Mental Health America’s Live Your Life Well website for tips and tools to cope with hardship and stay positive. You can also search for support groups in your community.

If you want to talk with someone and it’s not a crisis situation: Try the National Alliance on Mental Health Information Help Line at 1-800-950-NAMI (6264) for information and referrals.

If you’re thinking of hurting yourself: Call SAMHSA’s National Suicide Lifeline at 1-800-273-TALK (8255). You’ll speak with a trained counselor who will listen to you, guide you through your situation and help connect you with local resources. The line is staffed 24/7, and all conversations are confidential. 

“You don’t need to deal with it all alone,” Delany urges. “There are people out there who are ready to help you.”

Be An Ambassador for Happiness


, ,

Group of happy business people laughingBe an Ambassador for Happiness.  It’s all about sharing happiness. You can be responsible for your own happiness and become a catalyst of happiness in others. Just think what a difference your part of the world would be.  A world with more peace, optimism and compassion—it’s possible.

If we want the world to change, we have to be that change—start by choosing positivity and happiness.

True joy comes from spreading happiness to those around you. And like a pebble thrown into a pond, it only takes one person to create a ripple of happiness. This simple action by you can impact thousands of people. Are you ready?

Go to http://www.q96direct.com

Reduce stress with Empower plus Q96


, ,

Do you have too much stress?
Do you suffer from headaches, neck ache, stomach pain, sudden panic or constant worry?
  • Does your stress interfere with your work, school or personal life?
  • Do you feel like you are unable to relax?
  • Are you constantly worried about something to the point of physical illness?
  • Do you avoid certain situations and activities because they will cause you more stress?

The world renowned EMPowerplus Q96™ is the most studied micronutrient in the world.

Empower plus Q96



EMPowerplus Q96

 A proprietary formula of 36 vitamins and minerals, Q96 delivers nutrients  in a dosage that supports mood stability, cognition, and overall brain health.The Q96® formula has been observed by 39 research scientists in clinical trials at fourteen universities in four countries, and is backed by twenty published studies.

The unique formulation of Q96®, based on specialized technological advances in micronutrient delivery allows the body to rapidly absorb and utilize these essential nutrients for optimum physical and mental health. *

Key benefits:

  • Supports emotional wellbeing and mood stability, improved cognition and overall brain function.
  • Contains 36 ingredients proportioned for the best possible uptake of micronutrients in the body.
  • Chelated for increased bioavailability – a process wherein vital minerals are bound to proteins so the body can better digest them.
  • 96-hour micronization technology ensures that minerals are pulverized into a size that the body can effectively absorb.